Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Product defect recall alert
Huvepharma N.V have contacted wholesale dealers and veterinary surgeons to examine inventory immediately.

Gallifen 200 mg/ml Suspension and Pigfen 200 mg/ml Suspension.

The Veterinary Medicines Directorate (VMD) has issued a product defect recall alert for two products manufactured by Huvepharma N.V.

The recall affects the following finished products from the UK market:

  • two batches of Gallifen 200 mg/ml Suspension for Use in Drinking Water for Chickens and Pheasants
  • six batches of Pigfen 200 mg/ml Suspension for Use in Drinking Water for Pigs.

The VMD writes: 'Fenbendazole content has been found lower than the agreed specification limit and sediment/caking layer is present on bottom of the bottle...Huvepharma N.V have contacted wholesale dealers and veterinary surgeons to examine inventory immediately and quarantine products subject to this recall.'

The recall affects the following batches only:
 

Product
Batch No.
Expiry date
Gallifen 200mg/ml 19041748008 31/10/2021
Gallifen 200mg/ml 19091748023 30/03/2022
Pigfen 200mg/ml 18061747014 31/12/2020
Pigfen 200mg/ml 18091747020 30/03/2021
Pigfen 200mg/ml 19011747001 31/07/2021
Pigfen 200mg/ml 19031747019 30/09/2021


Further details can be obtained from Laura Kappelle Laura.Kappelle@huvepharma.com

 

Become a member or log in to add this story to your CPD history

Practices urged to audit neutering data

News Story 1
 RCVS Knowledge has called on vet practices to audit their post-operative neutering outcomes.

It follows the release of the 2024 NASAN benchmarking report, which collates data from neutering procedures performed on dogs, cats and rabbits.

The benchmarking report enables practices in the UK and Ireland to compare their post-operative outcomes to the national average. This includes the rate of patients lost to follow-up, which in 2024 increased to 23 per cent.

Anyone from the practice can submit the data using a free template. The deadline for next report is February 2026.

Visit the RCVS Knowledge website to complete an audit. 

Click here for more...
News Shorts
UK's BSE risk status downgraded

The WOAH has downgraded the UK's international risk status for BSE to 'negligible'.

Defra says that the UK's improved risk status recognises the reputation for having the highest standards for biosecurity. It adds that it demonstrates decades of rigorous animal control.

Outbreaks of Bovine Spongiform Encephalopathy, also known as mad cow disease, have previously resulted in bans on Britain's beef exports.

The UK's new status could lead to expanded trade and better confidence in British beef.

Christine Middlemiss, the UK's chief veterinary officer, said: "WOAH's recognition of the UK as negligible risk for BSE is a significant milestone and is a testament to the UK's strong biosecurity measures and the hard work and vigilance of farmers and livestock keepers across the country who have all played their part in managing the spread of this disease.